Second, the inhibitory effects of JapA on NFAT1-mediated MDM2 activation were demonstrated using breast cancer cells with NFAT1 OE or KD, as well as other pharmacological inhibitors and activators of calcineurin-NFAT signaling. Here, MDM2 is linked to breast cancer.